These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 188506)

  • 1. Cyclic AMP in the CSF of patients with schizophrenia.
    Biederman J; Rimon R; Ebstein R; Belmaker RH; Davidson JT
    Br J Psychiatry; 1977 Jan; 130():64-7. PubMed ID: 188506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
    Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
    Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotides in mental disorder.
    Belmaker RH; Zohar J; Ebstein RP
    Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
    Belmaker RH; Ebstein RP; Biederman J; Stern R; Berman M; van Praag HM
    Psychopharmacology (Berl); 1978 Jul; 58(3):307-10. PubMed ID: 210480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of CSF cyclic nucleotides in schizophrenia.
    Zohar J; Biederman J; Rimon R; Ebstein R; Belmaker RH
    Am J Psychiatry; 1978 Feb; 135(2):253-5. PubMed ID: 203200
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH; Dasberg H; Ebstein RP
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CSF concentrations of cyclic GMP in schizophrenia.
    Gattaz WF; Cramer H; Beckmann H
    Br J Psychiatry; 1983 Mar; 142():288-91. PubMed ID: 6134562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP in the cerebrospinal fluid of patients with recent cerebral infarction.
    Mrsulja BB; Djuricić BM; Kostić VS; Panić M
    Eur Neurol; 1984; 23(3):201-5. PubMed ID: 6088247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects of GABA and dopamine neurons during treatment with sulpiride.
    Zimmer R; Teelken AW; Cramer H; Ackenheil M; Zander KJ; Fischer H
    Adv Biochem Psychopharmacol; 1980; 24():537-9. PubMed ID: 6250324
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in cerebrospinal fluid cyclic nucleotides in alcohol-dependent patients suffering from delirium tremens.
    Zimmer R; Cramer H; Athen D; Beckmann H
    Biol Psychiatry; 1982 Jul; 17(7):837-43. PubMed ID: 6288126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CSF neurotensin concentration in drug-free schizophrenic patients.
    Lindström LH; Widerlöv E; Bisette G; Nemeroff C
    Schizophr Res; 1988; 1(1):55-9. PubMed ID: 3154507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.
    Licinio J; Seibyl JP; Altemus M; Charney DS; Krystal JH
    Am J Psychiatry; 1993 Sep; 150(9):1408-10. PubMed ID: 8102512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of cyclic adenosine monophosphate (cAMP) of the blood, urine and CSF in schizophrenics (author's transl)].
    Gao BL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):179-81. PubMed ID: 6277577
    [No Abstract]   [Full Text] [Related]  

  • 18. Low prolactin levels in cerebrospinal fluid: an after effect of lobotomy in chronic schizophrenia.
    Hyyppä MT; Liira J; Kampman R; Rimòn R
    Acta Psychiatr Belg; 1980; 80(4):452-7. PubMed ID: 7282416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of schizophrenia: assay of PG and cAMP in the CSF and plasma in 25 cases].
    Li E
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Apr; 20(2):81-3. PubMed ID: 3040348
    [No Abstract]   [Full Text] [Related]  

  • 20. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.